Cf Industries Holdings, Inc. CF
We take great care to ensure that the data presented and summarized in this overview for CF Industries Holdings, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CF
View all-
Vanguard Group Inc Valley Forge, PA21MShares$2 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY15.9MShares$1.51 Billion0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.97MShares$759 Million0.08% of portfolio
-
State Street Corp Boston, MA7.82MShares$744 Million0.03% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA6.06MShares$576 Million0.09% of portfolio
-
Invesco Ltd. Atlanta, GA5.71MShares$543 Million0.09% of portfolio
-
Geode Capital Management, LLC Boston, MA4.58MShares$436 Million0.03% of portfolio
-
Victory Capital Management Inc4.36MShares$415 Million0.37% of portfolio
-
Boston Partners Boston, MA3.62MShares$345 Million0.37% of portfolio
-
First Trust Advisors LP Wheaton, IL3.61MShares$343 Million0.26% of portfolio
Latest Institutional Activity in CF
Top Purchases
Top Sells
About CF
CF Industries Holdings, Inc. manufactures and sells hydrogen and nitrogen products for energy, fertilizer, emissions abatement, and other industrial activities worldwide. Its principal products include anhydrous ammonia, granular urea, urea ammonium nitrate, and ammonium nitrate products. The company also offers diesel exhaust fluid, urea liquor, nitric acid, and aqua ammonia products; and compound fertilizer products with nitrogen, phosphorus, and potassium. It primarily serves cooperatives, independent fertilizer distributors, traders, wholesalers, and industrial users. The company was founded in 1946 and is headquartered in Deerfield, Illinois.
Insider Transactions at CF
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 20
2025
|
Susan L Menzel EVP and Chief Admin. Officer |
SELL
Open market or private sale
|
Direct |
10,000
-10.21%
|
$1,000,000
$100.23 P/Share
|
|
Jun 17
2025
|
Gregory D Cameron EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,699
-10.2%
|
$377,298
$102.48 P/Share
|
|
Jun 16
2025
|
Bert A Frost EVP,Sales,MktDev&Supply Chain |
SELL
Open market or private sale
|
Direct |
10,003
-5.12%
|
$1,000,300
$100.86 P/Share
|
|
Jun 13
2025
|
Bert A Frost EVP,Sales,MktDev&Supply Chain |
SELL
Open market or private sale
|
Direct |
16,000
-7.04%
|
$1,552,000
$97.83 P/Share
|
|
Jun 13
2025
|
Ashraf K Malik Sr. VP, Manufacturing & D'istn |
SELL
Open market or private sale
|
Direct |
5,498
-27.4%
|
$544,302
$99.95 P/Share
|
|
May 13
2025
|
Robert C Arzbaecher Director |
SELL
Bona fide gift
|
Direct |
13,175
-5.97%
|
-
|
|
May 06
2025
|
Celso L. White Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,074
+8.6%
|
-
|
|
May 06
2025
|
Michael Toelle Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,074
+7.4%
|
-
|
|
May 06
2025
|
Theresa E Wagler Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,074
+5.58%
|
-
|
|
May 06
2025
|
Stephen J Hagge Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,293
+5.21%
|
-
|
|
May 06
2025
|
Yris Jesus Madrazo Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,074
+15.76%
|
-
|
|
May 06
2025
|
Anne P Noonan Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,074
+5.97%
|
-
|
|
May 06
2025
|
Robert C Arzbaecher Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,074
+2.6%
|
-
|
|
May 06
2025
|
John W Eaves Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,074
+7.4%
|
-
|
|
May 06
2025
|
Susan A Ellerbusch Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,074
+25.9%
|
-
|
|
May 06
2025
|
Javed Ahmed Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,074
+8.7%
|
-
|
|
May 06
2025
|
Deborah L De Haas Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,074
+16.06%
|
-
|
|
Feb 28
2025
|
Christopher D Bohn EVP and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,219
-4.66%
|
$665,739
$81.02 P/Share
|
|
Feb 28
2025
|
Christopher D Bohn EVP and COO |
BUY
Grant, award, or other acquisition
|
Direct |
18,639
+9.56%
|
-
|
|
Feb 28
2025
|
Susan L Menzel EVP and Chief Admin. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,328
-5.16%
|
$431,568
$81.02 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 297K shares |
|---|---|
| Bona fide gift | 5.12K shares |
| Payment of exercise price or tax liability | 102K shares |
|---|---|
| Open market or private sale | 83.4K shares |
| Bona fide gift | 18.3K shares |